Essex Management, an Emmes Group company, has appointed David Loose as Chief Executive Officer (CEO), effective immediately.

Loose succeeds Kevin Hurley, who served as CEO since February 2019 and will transition to the role of Executive Advisor.

Experience

Loose joined Essex Management as a partner in February 2009 and has played a pivotal role in the company’s growth. Starting as Vice President for Business Operations and Development, he later served as Chief Business Officer, overseeing critical operations, driving client-focused innovation, and delivering strategic initiatives such as NCI’s Clinical Trials Reporting Program (CTRP).

“David’s leadership and dedication to Essex’s mission make him the ideal choice to guide the company forward,” said Sastry Chilukuri, CEO of Emmes Group. “His focus on innovation and client success will ensure Essex continues to deliver transformative solutions in biomedical informatics and health IT.”

Under Loose’s leadership, Essex Management hopes to build on its legacy of navigating the complexities of scientific computing to save lives and improve the quality of care.